Genotypic Stability, Segregation and Selection in Heteroplasmic Human Cell Lines Containing np 3243 Mutant mtDNA

Corresponding author: Howard T. Jacobs, Institute of Medical Technology, University of Tampere, P.O. Box 607, 33101 Tampere, Finland., howy.jacobs{at}uta.fi (E-mail)

Communicating editor: K. J. NEWTON

The mitochondrial genotype of heteroplasmic human cell lines containing the pathological np 3243 mtDNA mutation, plus or minus its suppressor at np 12300, has been followed over long periods in culture. Cell lines containing various different proportions of mutant mtDNA remained generally at a consistent, average heteroplasmy value over at least 30 wk of culture in nonselective media and exhibited minimal mitotic segregation, with a segregation number comparable with mtDNA copy number (1000). Growth in selective medium of cells at 99% np 3243 mutant mtDNA did, however, allow the isolation of clones with lower levels of the mutation, against a background of massive cell death. As a rare event, cell lines exhibited a sudden and dramatic diversification of heteroplasmy levels, accompanied by a shift in the average heteroplasmy level over a short period (<8 wk), indicating selection. One such episode was associated with a gain of chromosome 9. Analysis of respiratory phenotype and mitochondrial genotype of cell clones from such cultures revealed that stable heteroplasmy values were generally reestablished within a few weeks, in a reproducible but clone-specific fashion. This occurred independently of any straightforward phenotypic selection at the individual cell-clone level. Our findings are consistent with several alternate views of mtDNA organization in mammalian cells. One model that is supported by our data is that mtDNA is found in nucleoids containing many copies of the genome, which can themselves be heteroplasmic, and which are faithfully replicated. We interpret diversification and shifts of heteroplasmy level as resulting from a reorganization of such nucleoids, under nuclear genetic control. Abrupt remodeling of nucleoids in vivo would have major implications for understanding the developmental consequences of heteroplasmy, including mitochondrial disease phenotype and progression.

This article has been cited by other articles:

				R. S. Jahangir Tafrechi, F. M. van de Rijke, A. Allallou, C. Larsson, W. C.R. Sloos, M. van de Sande, C. Wahlby, G. M.C. Janssen, and A. K. Raap Single-cell A3243G Mitochondrial DNA Mutation Load Assays for Segregation Analysis J. Histochem. Cytochem., November 1, 2007; 55(11): 1159 - 1166. [Abstract] [Full Text] [PDF]

				J. L. O. Pohjoismaki, S. Wanrooij, A. K. Hyvarinen, S. Goffart, I. J. Holt, J. N. Spelbrink, and H. T. Jacobs Alterations to the expression level of mitochondrial transcription factor A, TFAM, modify the mode of mitochondrial DNA replication in cultured human cells Nucleic Acids Res., November 6, 2006; 34(20): 5815 - 5828. [Abstract] [Full Text] [PDF]

				Y. Kirino, T. Yasukawa, S. K. Marjavaara, H. T. Jacobs, I. J. Holt, K. Watanabe, and T. Suzuki Acquisition of the wobble modification in mitochondrial tRNALeu(CUN) bearing the G12300A mutation suppresses the MELAS molecular defect Hum. Mol. Genet., March 15, 2006; 15(6): 897 - 904. [Abstract] [Full Text] [PDF]

				C. J. Turner, C. Granycome, R. Hurst, E. Pohler, M. K. Juhola, M. I. Juhola, H. T. Jacobs, L. Sutherland, and I. J. Holt Systematic Segregation to Mutant Mitochondrial DNA and Accompanying Loss of Mitochondrial DNA in Human NT2 Teratocarcinoma Cybrids Genetics, August 1, 2005; 170(4): 1879 - 1885. [Abstract] [Full Text] [PDF]

				H. T. Jacobs Disorders of mitochondrial protein synthesis Hum. Mol. Genet., October 15, 2003; 12(90002): R293 - 301. [Abstract] [Full Text] [PDF]

				N. Garrido, L. Griparic, E. Jokitalo, J. Wartiovaara, A. M. van der Bliek, and J. N. Spelbrink Composition and Dynamics of Human Mitochondrial Nucleoids Mol. Biol. Cell, April 1, 2003; 14(4): 1583 - 1596. [Abstract] [Full Text] [PDF]

				R. Acin-Perez, M. P. Bayona-Bafaluy, M. Bueno, C. Machicado, P. Fernandez-Silva, A. Perez-Martos, J. Montoya, M.J. Lopez-Perez, J. Sancho, and J. A. Enriquez An intragenic suppressor in the cytochrome c oxidase I gene of mouse mitochondrial DNA Hum. Mol. Genet., February 1, 2003; 12(3): 329 - 339. [Abstract] [Full Text] [PDF]

				M. D'Aurelio, F. Pallotti, A. Barrientos, C. D. Gajewski, J. Q. Kwong, C. Bruno, M. F. Beal, and G. Manfredi In Vivo Regulation of Oxidative Phosphorylation in Cells Harboring a Stop-codon Mutation in Mitochondrial DNA-encoded Cytochrome c Oxidase Subunit I J. Biol. Chem., December 7, 2001; 276(50): 46925 - 46932. [Abstract] [Full Text] [PDF]

				V. W. S. Liu, H. H. Shi, A. N. Y. Cheung, P. M. Chiu, T. W. Leung, P. Nagley, L. C. Wong, and H. Y. S. Ngan High Incidence of Somatic Mitochondrial DNA Mutations in Human Ovarian Carcinomas Cancer Res., August 1, 2001; 61(16): 5998 - 6001. [Abstract] [Full Text] [PDF]

				J. B. Jones, J. J. Song, P. M. Hempen, G. Parmigiani, R. H. Hruban, and S. E. Kern Detection of Mitochondrial DNA Mutations in Pancreatic Cancer Offers a "Mass"-ive Advantage over Detection of Nuclear DNA Mutations Cancer Res., February 1, 2001; 61(4): 1299 - 1304. [Abstract] [Full Text]

				J. N. Spelbrink, J. M. Toivonen, G. A. J. Hakkaart, J. M. Kurkela, H. M. Cooper, S. K. Lehtinen, N. Lecrenier, J. W. Back, D. Speijer, F. Foury, et al. In Vivo Functional Analysis of the Human Mitochondrial DNA Polymerase POLG Expressed in Cultured Human Cells J. Biol. Chem., August 4, 2000; 275(32): 24818 - 24828. [Abstract] [Full Text] [PDF]